| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
GSE209647
|
||||||||
| GSM6381776 |
MC38_wt_TIC, mRNA-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381777 |
MC38_wt_TIC, ADT- and HTO-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381778 |
MC38_wt_BM_blood, mRNA-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381779 |
MC38_wt_BM_blood, ADT- and HTO-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381780 |
MC38_JAK1ko_TIC and LCMV_S, mRNA-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381781 |
MC38_JAK1ko_TIC and LCMV_S, ADT- and HTO-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381782 |
EL4_TIC, mRNA-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381783 |
EL4_TIC, ADT- and HTO-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381784 |
LLC1_TIC, mRNA-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381785 |
LLC1_TIC, ADT- and HTO-derived cDNA
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381786 |
tumor-infiltrating NK cells, vehicle treated mice
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381787 |
tumor-infiltrating NK cells, ICB treated mice
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381788 |
tumor-infiltrating NK cells, ruxolitinib treated mice
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 | |||
| GSM6381789 |
tumor-infiltrating NK cells, ICB and ruxolitinib treated mice
|
SRA | 1 |
|
John R Teijaro | Jun 20, 2024 |
